{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:26:07Z","timestamp":1793352367615,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To evaluate the musculoskeletal (MSK) symptoms experienced by SLE patients and determine how those symptoms relate to their health-related quality of life (HRQoL).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This is a cross-sectional study that was carried out on 103 adult SLE patients. sociodemographic, clinical, and therapeutic data were recruited. They were asked to complete the following: Nordic Musculoskeletal, Short-Form McGill Pain, and Lupus QoL Questionnaires.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age was 30.81\u2009\u00b1\u20099.44 years. There was a total of 86 females and 17 males (F: M:5:1). Almost all the patients reported MSK symptoms (96.1%). The maximum number of patients reported pain in the right and left wrist and hand (64.1%, 63.1%, respectively). One-fourth (25.2%) described at least five bodily sites of MSK symptoms, while 70.9% had more than five sites of MSK symptoms. Most of the patients described the pain as discomforting (40.8%). Patients with MSK symptoms scored significantly worse in all domains. In addition, the QoL scores of patients with more than 5 body sites of MSK symptoms were significantly lower than those of patients with fewer than 5 sites of MSK symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SLE patients have a high MSK burden, and MSK symptoms have a negative impact on HRQoL in these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-024-07367-4","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:02:20Z","timestamp":1712588540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Musculoskeletal symptoms in systemic lupus erythematosus patients and their impact on health-related quality of life"],"prefix":"10.1186","volume":"25","author":[{"given":"Samar","family":"Tharwat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mahmood","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"7367_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1177\/09612033211014253","volume":"30","author":"TA Gheita","year":"2021","unstructured":"Gheita TA, Noor RA, Abualfadl E, Abousehly OS, El-Gazzar II, El Shereef RR, et al. Adult systemic lupus erythematosus in Egypt: the nation-wide spectrum of 3661 patients and world-wide standpoint. Lupus. 2021;30:1526\u201335.","journal-title":"Lupus"},{"key":"7367_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet Lond Engl. 2019;393:2344\u201358.","journal-title":"Lancet Lond Engl"},{"key":"7367_CR3","doi-asserted-by":"crossref","unstructured":"N AF, Dt TGB. B. Update \u03bfn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80.","DOI":"10.1136\/annrheumdis-2020-218272"},{"key":"7367_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/096120339500400303","volume":"4","author":"DP Symmons","year":"1995","unstructured":"Symmons DP. Frequency of lupus in people of African origin. Lupus. 1995;4:176\u20138.","journal-title":"Lupus"},{"key":"7367_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","volume":"39","author":"GJ Pons-Estel","year":"2010","unstructured":"Pons-Estel GJ, Alarc\u00f3n GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010;39:257\u201368.","journal-title":"Semin Arthritis Rheum"},{"key":"7367_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","volume":"16","author":"DS Pisetsky","year":"2020","unstructured":"Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020;16:565\u201379.","journal-title":"Nat Rev Rheumatol"},{"key":"7367_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5152\/eurjrheum.2017.17198","volume":"5","author":"V Torrente-Segarra","year":"2018","unstructured":"Torrente-Segarra V, Monte TCS, Corominas H. Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: new insights and review. Eur J Rheumatol. 2018;5:127\u201330.","journal-title":"Eur J Rheumatol"},{"key":"7367_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1191\/0961203303lu2021oa","volume":"13","author":"A Zoma","year":"2004","unstructured":"Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus. 2004;13:851\u20133.","journal-title":"Lupus"},{"key":"7367_CR9","doi-asserted-by":"publisher","first-page":"e0170209","DOI":"10.1371\/journal.pone.0170209","volume":"12","author":"I Etchegaray-Morales","year":"2017","unstructured":"Etchegaray-Morales I, M\u00e9ndez-Mart\u00ednez S, Jim\u00e9nez-Hern\u00e1ndez C, Mendoza-Pinto C, Alonso-Garc\u00eda NE, Montiel-Jarqu\u00edn A, et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus patients using the LupusQol. PLoS ONE. 2017;12:e0170209.","journal-title":"PLoS ONE"},{"key":"7367_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0961203320979039","volume":"30","author":"F Natalucci","year":"2021","unstructured":"Natalucci F, Ceccarelli F, Cipriano E, Perricone C, Olivieri G, Pirone C, et al. Joint involvement influences quality of life in systemic lupus erythematosus patients. Lupus. 2021;30:478\u201383.","journal-title":"Lupus"},{"key":"7367_CR11","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic Lupus International collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677\u201386.","journal-title":"Arthritis Rheum"},{"key":"7367_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis"},{"key":"7367_CR13","first-page":"14","volume":"81","author":"General Assembly of the World Medical Association","year":"2014","unstructured":"General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14\u20138.","journal-title":"J Am Coll Dent"},{"key":"7367_CR14","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"7367_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-323-04434-9.50007-5","volume-title":"Systemic Lupus Erythematosus","author":"M Mosca","year":"2007","unstructured":"Mosca M, Merrill JT, Bombardieri S. Chapter 2 - Assessment of Disease activity in systemic Lupus Erythematosus. In: Tsokos GC, Gordon C, Smolen JS, editors. Systemic Lupus Erythematosus. Philadelphia: Mosby; 2007. pp. 19\u201323."},{"key":"7367_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0003-6870(87)90010-X","volume":"18","author":"I Kuorinka","year":"1987","unstructured":"Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-S\u00f8rensen F, Andersson G, et al. Standardised nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon. 1987;18:233\u20137.","journal-title":"Appl Ergon"},{"key":"7367_CR17","unstructured":"Factorial validity of the short-. form McGill pain questionnaire (SF\u2010MPQ) - Wright \u2013\u20092001 - European Journal of Pain - Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1053\/eujp.2001.0243?sid=nlm%3Apubmed. Accessed 26 Mar 2023."},{"issue":"Suppl 1","key":"7367_CR18","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.4103\/sja.SJA_42_17","volume":"11","author":"AS Terkawi","year":"2017","unstructured":"Terkawi AS, Tsang S, Abolkhair A, Alsharif M, Alswiti M, Alsadoun A, et al. Development and validation of arabic version of the short-form McGill Pain Questionnaire. Saudi J Anaesth. 2017;11(Suppl 1):S2\u201310.","journal-title":"Saudi J Anaesth"},{"key":"7367_CR19","first-page":"9472925","volume":"2017","author":"MB Passavanti","year":"2017","unstructured":"Passavanti MB, Pota V, Sansone P, Aurilio C, De Nardis L, Pace MC. Chronic Pelvic Pain: Assessment, evaluation, and Objectivation. Pain Res Treat. 2017;2017:9472925.","journal-title":"Pain Res Treat"},{"key":"7367_CR20","doi-asserted-by":"crossref","unstructured":"Kd W, Gj A, Dr M. Factorial validity of the short-form McGill pain questionnaire (SF-MPQ). Eur J Pain Lond Engl. 2001;5.","DOI":"10.1053\/eujp.2001.0243"},{"key":"7367_CR21","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.22881","volume":"57","author":"K McElhone","year":"2007","unstructured":"McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007;57:972\u20139.","journal-title":"Arthritis Rheum"},{"key":"7367_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/BOR.0000000000000421","volume":"29","author":"K Mahmoud","year":"2017","unstructured":"Mahmoud K, Zayat A, Vital EM. Musculoskeletal manifestations of systemic lupus erythmatosus. Curr Opin Rheumatol. 2017;29:486\u201392.","journal-title":"Curr Opin Rheumatol"},{"key":"7367_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.22578","volume":"56","author":"A Nzeusseu Toukap","year":"2007","unstructured":"Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJU, Houssiau FA, et al. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 2007;56:1579\u201388.","journal-title":"Arthritis Rheum"},{"key":"7367_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/annrheumdis-2015-207653","volume":"75","author":"DA Isenberg","year":"2016","unstructured":"Isenberg DA, Petri M, Kalunian K, Tanaka Y, Urowitz MB, Hoffman RW, et al. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016;75:323\u201331.","journal-title":"Ann Rheum Dis"},{"key":"7367_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/rheumatology\/ker381","volume":"51","author":"EMA Ball","year":"2012","unstructured":"Ball EMA, Bell AL. Lupus arthritis\u2013do we have a clinically useful classification? Rheumatol Oxf Engl. 2012;51:771\u20139.","journal-title":"Rheumatol Oxf Engl"},{"issue":"2 Suppl 96","key":"7367_CR26","first-page":"S40","volume":"34","author":"V Torrente-Segarra","year":"2016","unstructured":"Torrente-Segarra V, Salman-Monte TC, R\u00faa-Figueroa \u00cd, P\u00e9rez-Vicente S, L\u00f3pez-Longo FJ, Galindo-Izquierdo M, et al. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S40\u201347.","journal-title":"Clin Exp Rheumatol"},{"issue":"6 Suppl 74","key":"7367_CR27","first-page":"117","volume":"30","author":"C Iannuccelli","year":"2012","unstructured":"Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, et al. Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol. 2012;30(6 Suppl 74):117\u201321.","journal-title":"Clin Exp Rheumatol"},{"key":"7367_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/ard.2003.018127","volume":"64","author":"C Yee","year":"2005","unstructured":"Yee C, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis. 2005;64:111\u20133.","journal-title":"Ann Rheum Dis"},{"key":"7367_CR29","doi-asserted-by":"publisher","first-page":"e000098","DOI":"10.1136\/lupus-2015-000098","volume":"3","author":"L Carli","year":"2016","unstructured":"Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, et al. Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med. 2016;3:e000098.","journal-title":"Lupus Sci Med"},{"key":"7367_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/CRIAI:25:1:13","volume":"25","author":"M Abu-Shakra","year":"2003","unstructured":"Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol. 2003;25:13\u201324.","journal-title":"Clin Rev Allergy Immunol"},{"key":"7367_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1177\/0961203320945379","volume":"29","author":"FF Huang","year":"2020","unstructured":"Huang FF, Fang R, Nguyen MH, Bryant K, Gibson KA, O\u2019Neill SG. Identifying co-morbid fibromyalgia in patients with systemic lupus erythematosus using the Multi-dimensional Health Assessment Questionnaire. Lupus. 2020;29:1404\u201311.","journal-title":"Lupus"},{"key":"7367_CR32","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202003030","volume":"172","author":"MJ Bair","year":"2020","unstructured":"Bair MJ, Krebs EE, Fibromyalgia. Ann Intern Med. 2020;172:ITC33\u201348.","journal-title":"Ann Intern Med"},{"key":"7367_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1191\/0961203303lu330oa","volume":"12","author":"AW Friedman","year":"2003","unstructured":"Friedman AW, Tewi MB, Ahn C, McGwin G, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia. Lupus. 2003;12:274\u20139.","journal-title":"Lupus"},{"issue":"6 Suppl 63","key":"7367_CR34","first-page":"S22","volume":"28","author":"V Torrente-Segarra","year":"2010","unstructured":"Torrente-Segarra V, Carbonell-Abell\u00f3 J, Castro-Oreiro S, Manresa Dom\u00ednguez JM. Association between Fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S22\u201326.","journal-title":"Clin Exp Rheumatol"},{"key":"7367_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.autrev.2016.02.019","volume":"15","author":"A Floris","year":"2016","unstructured":"Floris A, Piga M, Cauli A, Mathieu A. Predictors of flares in systemic Lupus Erythematosus: preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review. Autoimmun Rev. 2016;15:656\u201363.","journal-title":"Autoimmun Rev"},{"key":"7367_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0961203312468625","volume":"22","author":"E Waldheim","year":"2013","unstructured":"Waldheim E, Elkan A-C, Bergman S, Frosteg\u00e5rd J, van Vollenhoven R, Henriksson EW. Extent and characteristics of self-reported pain in patients with systemic lupus erythematosus. Lupus. 2013;22:136\u201343.","journal-title":"Lupus"},{"key":"7367_CR37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0961203313502109","volume":"22","author":"E Waldheim","year":"2013","unstructured":"Waldheim E, Elkan A-C, Pettersson S, van Vollenhoven R, Bergman S, Frosteg\u00e5rd J, et al. Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus. 2013;22:1118\u201327.","journal-title":"Lupus"},{"key":"7367_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10067-015-3127-3","volume":"35","author":"NWS Gormezano","year":"2016","unstructured":"Gormezano NWS, Silva CA, Aikawa NE, Barros DL, da Silva MA, Otsuzi CI, et al. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients. Clin Rheumatol. 2016;35:227\u201331.","journal-title":"Clin Rheumatol"},{"key":"7367_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/03009742.2012.677857","volume":"41","author":"S Pettersson","year":"2012","unstructured":"Pettersson S, L\u00f6vgren M, Eriksson LE, Moberg C, Svenungsson E, Gunnarsson I, et al. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol. 2012;41:383\u201390.","journal-title":"Scand J Rheumatol"},{"key":"7367_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/rheumatology\/ken477","volume":"48","author":"K Baker","year":"2009","unstructured":"Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatol Oxf Engl. 2009;48:281\u20134.","journal-title":"Rheumatol Oxf Engl"},{"key":"7367_CR41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.24108","volume":"59","author":"P Malcus Johnsson","year":"2008","unstructured":"Malcus Johnsson P, Sandqvist G, Bengtsson A, Nived O. Hand function and performance of daily activities in systemic lupus erythematosus. Arthritis Rheum. 2008;59:1432\u20138.","journal-title":"Arthritis Rheum"},{"key":"7367_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/art.20409","volume":"51","author":"GS Alarc\u00f3n","year":"2004","unstructured":"Alarc\u00f3n GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51:465\u201374.","journal-title":"Arthritis Rheum"},{"key":"7367_CR43","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/rheumatology\/ket171","volume":"52","author":"AN Kiani","year":"2013","unstructured":"Kiani AN, Strand V, Fang H, Jaranilla J, Petri M. Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatol Oxf Engl. 2013;52:1651\u20137.","journal-title":"Rheumatol Oxf Engl"},{"key":"7367_CR44","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-024-07367-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:04:02Z","timestamp":1712592242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-024-07367-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7367"],"URL":"https:\/\/doi.org\/10.1186\/s12891-024-07367-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"28 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Research Board of the Faculty of Medicine at Mansoura University provided its approval (Approval No: R.23.04.2145). The work was conducted according to the principles mentioned in the Helsinki Declaration []. Participation in the study was completely voluntary and confidential. The objective of the study was explained in depth, and informed consent was obtained. In the case of participants who were illiterate or otherwise incapable of providing informed consent, parental or legal guardian consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}